chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a Registered Nurse refers to an unspecified number of patients of unknown age and gender. Medical histories and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) (administration routes, lot numbers and expiration dates were not provided). No concomitant medications were reported. No adverse effects were reported. Additional information has been requested.
Severe Headaches, Eye Pressure, and pain extended all the way to the back of my head. Joint pain is constant, especially in the legs.
12 hours after receiving the vaccine shivering began and increased to the point of severe full body shaking and lasted about 2 hours. Then a fever of 101.5, with a throbbing headache. There was localized redness and swelling at the injection point which occurred shortly after the injection.
On the 22nd, my left arm was sore after the shot - akin to a flu shot. Yesterday, the 23rd, the pain in my left arm increased. For about six hours, on the 23rd, I had a shooting pain from my left armpit down arm to tips of 4th and 5th fingers. When I awoke this morning,  the intense shooting arm pain was gone, although I cried out in pain when my daughter touched the site of my shot. Around 9am, I experienced intense fatigue and slept intermittently until noon, about 2.5 hours. Around  3:30pm I experienced  very loose bowel movements, on two occasions. After each of the two loose bowel movements, I took immodium.
Pt found out wife was pregnant (8 weeks pregnant) at time of vaccination. Did not inform staff until after administration.
Fever, body aches, weakness, dizziness, exhaustion, headaches, loss of appetite - gradually improving over 2-3 week period. However, I continue to experience exhaustion, weakness, dizziness and brain fog most days at varying degrees. My acid reflux has become much worse and I experience more anxiety now. A general feeling of malaise.
Developed fever and headache after receiving vaccine. 1st vaccine had fever after 72 hours, developed cold symptoms and intestinal issues after 6 days. 2nd vaccine fever developed 26 hours after receiving, now 28 hours later having aches and headache and abdominal pain.
Approximately 2 days after getting vaccination, pt got a fever and seizure. Pt was taken to the ER. Pt had a normal head CT at that time. pt has done fine since that time.
Pleurisy - Severe pain around left lung for about 4 days. I've had it diagnosed before. Did not see doctor this time. Treated at home. It is almost resolved now.
A report was received from a health care professional on 11/19/03 concerning a 6 month old female vaccinee who inadvertently received Fluvirin sometime during the week of 11/10/03. On an unspecified date in November 2003, a 6 month old female vaccinee inadvertently received Fluvirin. At the time of the report, no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Two months after the second Pfizer vaccination, we noticed that our 13-year old daughter developed hair loss, which our dermatologist diagnosed as alopecia areata. And at the same time, our 15-year old daughter developed pityriasis rosea. The family pediatrician diagnosed this, and it cleared within 6 weeks. We thought it was notable that both of our very healthy daughters developed something out of the ordinary two months after the second vaccination. Upon further reading, it appears that there have been numerous reports of both alopecia areata and pityriasis rosea being caused by both Covid-19 and the Covid-19 vaccine. Our family has been very careful, and no one has so far caught Covid-19, and we have all been double vaccinated and boostered (except for our 13-year old daughter, who has been double-vaccinated, but not boostered because we were concerned whether the booster shot would further the alopecia problem).  Our 13-year old daughter has been losing large amounts of hair since August (8 months ago), and unfortunately she is continuing to lose hair. Dermatology Center, has treated my daughter for the past 8 months. Our family strongly supports vaccines, though I have to admit that after what my daughter has been through and continues to go through, we are concerned about giving her future does of the vaccine since this seemed to develop shortly after the vaccine. Before this, our daughter was in great health.
Patient was departing clinic after her 15 minute wait. She returned to tell nurse that she was experiencing tingling/numbness radiating from the injection site (L deltoid) to her face/neck and down the left side of her body and leg. VS were within normal limits and stable. After 50 minutes of observation, she had improved. But, tingling at the site of injection remained. She was discharge with her husband with instructions to see medical treatment if symptoms returned.
Vomiting, fever 103, headaches, redness, swelling size of an egg.
Patient with history of COPD, myocardial infarction, and diabetes type II. He was seen in the ED on 1/23/23 with one week of productive cough, dizziness, and shortness of breath. Patient did note his dizziness has been present for months but has worsened. COVID-19 PCR test performed in the ED resulted positive. Chest x-ray was suggestive of COVID infection with early COVID pneumonia. Patient was admitted on 1/23/23 for dizziness that had worsened; this was felt to be secondary to COVID infection. He was discharged 1/25/23. Patient has received the primary COVID vaccine series and booster x2.
Left thigh, top and inner side, red, swollen and warm to touch. Given Zithromax and Zyrtec.
I had a fever/ aches/chills the next day 5/19/21 and on 5/20/21 I developed bump hive rash on face/chest/ shoulders/ whole back .
Itching started along s2 dermatome on 4/25. Rash became visible and worsened over following days. By 4/30 rash was red, blisters started forming and rash spread. Blisters have since worsened and the pain is excruciating . Noticed swollen lymph node in groin area on the same side as shingles rash on 4/28 and area has swollen further since. Currently area is very visibly swollen and sore.
The evening following day of vaccination, pt noted pain, swelling and redness to upper arm triceps. He presented to our clinic on 2/2/04. He had increased warmth and erythema to almost entire arm, with swelling of triceps and TTP, decreased sensation to touch. Diagnosed with cellulitis. Necrotizing fasciitis. Resolved 100% 2/6/04 at f/u post Keflex 500mg po TID.
Trigeminal neuralgia; glossopharyngeal neuralgia; This case was reported by a consumer via call center representative and described the occurrence of trigeminal neuralgia in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In February 2020, the patient received the 1st dose of Shingrix (intramuscular). In April 2020, between 1 and 3 months after receiving Shingrix, the patient experienced trigeminal neuralgia and glossopharyngeal neuralgia. On an unknown date, the outcome of the trigeminal neuralgia was not recovered/not resolved and the outcome of the glossopharyngeal neuralgia was unknown.   It was unknown if the reporter considered the trigeminal neuralgia and glossopharyngeal neuralgia to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix in left arm and was diagnosed with Trigeminal and glossopharyngeal neuralgia. The patient had concern that the condition was related to the vaccination and had not received her second dose yet. The reporter consented to follow up.
Tremendous flare ups/a rheumatoid reaction; Knees swelled up/ ankles swelled up; Feet swelled up; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: ER8727) as DOSE 1, SINGLE, dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot Number: ER8730) as DOSE 2, SINGLE for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. The patient had tremendous flare ups from both of those doses. She was in bed for like 3 days with both of those doses. It was definitely a rheumatoid reaction. Her knees swelled up, her feet swelled up and her ankles swelled up. The outcomes of events were unknown.   Follow-up attempts are completed. No further information is expected.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.    In 2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot# and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions. On an unknown date, subsequent to zoster vaccine live (ZOSTAVAX) inoculation, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of use of zoster vaccine live (ZOSTAVAX), patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of herpes zoster was unknown.   Additional information is not expected.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. On 22-SEP-2017, the patient was vaccinated with improperly stored VARIVAX lot # N015477, expiry date: 18-MAY-2019 (dose and route of administration were not provided). The properly stored sterile diluent (STERILE DILUENT) was used to reconstitute the vaccine. The vaccine had been stored in temperature of 11.5 Fahrenheit degrees for 15 hours. There was no previous temperature excursion. Digital data logger was involved. No adverse event was reported.
Information has been received from a consumer concerning her daughter who was vaccinated with GARDASIL vaccine (yeast). The patient's mother reported that her daughter. Subsequently she experienced shortness of breath, rapid heart beat, dizziness and headaches. Outcome was not reported. Additional information is not expedited.
A 17 year old student experienced itchiness and tingly on his arms about 15 minutes after vaccination. The nurses on site evaluated him and spoke to doctor on the phone. He was given 12.5mg of Benadryl orally at 1:15pm. At 1:25pm, he was given an ice pack to cool down itchiness. By this time, the itchiness had spread to his legs.
The events have been injection site pain, arm soreness, headaches, dizziness, nausea, diarrheas, swelling, and vomits.
sore arm; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 01907850.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  Additional Information: Caller who was calling on patient's behalf. Merck field employee reported other company adverse event on patient's behalf. Patient was never on the line. Patient who previously was administered the PFIZER COVID 10 Vaccine on unknown, previous date had experienced a sore arm on unknown, previous date after receiving the 1st and 2nd PFIZER COVID 19 Vaccine doses. At same reporting time, Patient mentioned a separate, unknown patient who was administered the PFIZER COVID 19 Vaccine on unknown, previous date and had experienced a sore arm on unknown previous date after receiving the 1st and 2nd PFIZER COVID 19 Vaccine doses. Also at same reporting time, Patient mentioned a separate, unknown patient who was administered MODERNA COVID 19 vaccine and had become ill after receiving the 1st and 2nd MODERNA COVID 19 Vaccine doses. Employee had extremely limited information at call time. No additional adverse event. No PQC. No further information available. Please note that this information has not been reported to the FDA. If you have any questions, Please contact.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021446495 Same reporter/ drug/ event for different patients
The patient received the Flu vaccine on 10/12/2010. On 02/22/2011 the patient reported that she had been experiencing more frequent seizure events, and been sick like having a flu after the flu shot.
I had moderate vaginal bleedings each and every morning; This abnormal spotting was going on, non stop, for 3 months.; fully sick for a week; fever; chills; This is a spontaneous report from a contactable consumer (Patient). A 32-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on 09Apr2021 as dose 2, single for covid-19 immunization (Vaccinated at 32-years age). Medical history included known allergies: Strawberry. There were no concomitant medications. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Ep7534), via an unspecified route of administration in arm left on 16Mar2021 as dose 1, single for covid-19 immunization (Vaccinated at 32-years age). Facility where the most recent Covid-19 vaccine was administered was Workplace clinic. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with Covid-19. Patient did not received any other vaccines within 4 weeks prior to the Covid vaccine. On 03May2021, the patient had moderate vaginal bleedings each and every morning, this abnormal spotting was going on, non stop, for 3 months, fully sick for a week, fever, chills. It was reported that after the periods following her second shot (09Apr2021) she had moderate vaginal bleedings each and every morning. This abnormal spotting was going on, non stop, for 3 months. She saw an obgyn who tested her for about anything without finding anything. No progesterone amount would stop it. never had hormonal issues before, so this was concerning. The bleeding stopped after three months. She was fully sick for a week following the second shot (done having about all the side effects advertised, chills, fever, etc). Since the vaccination, patient has been tested for Covid-19. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included biopsy: unknown result, Nasal Swab: negative on 15Jul2021, scan: unknown result, x-ray: unknown result. Events were assessed as medically significant by the reporter. Therapeutic measures were taken as a result of all events. Treatment received for the adverse event included testing, biopsy, xray, scan, progesterone. Outcome of all the events was unknown.  Information on the Batch/lot number has been requested.
I have been having dizzy spells off and on, mostly on, since receiving this vaccine. Talked to my doctor about this and he said that he found it specious that these dizzy spells started right after receiving the vaccine.  In my opinion these dizzy spells should be gone by now,  March 24, yet they seem to be getting worst . The handout shows that dizziness could be a sign of an allergic reaction, so that is why I am reporting this.  My doctor said I should get the second shot, and I will, but I really don't feel very comfortable about getting it.
She is feeling sick; her arm was very sore; headache; she doesn't feel good and is tired; she doesn't feel good and is tired; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable 53-year-old female Nurse reported for herself.  A 53-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Formulation: Solution for injection, Lot number: EL9265 and expiration date: 31May2021) via an unspecified route of administration, administered in left deltoid on 29Jan2021 at 10-10:30am (at the age of 53-year-old) as single dose for COVID-19 immunization. The patient medical history included a shingles in Nov2020, breast cancer, it is non-metastatic triple negative and Covid virus where she had headache, was sick for 2 full weeks and then on the 3rd week she felt better. The patient's concomitant medications were not reported. The patient did not had allergies. The patient did not have any illness at time of vaccination. On 30Jan2021, the patient's arm was sore and very sore when she touches it the first day after, she put a cold compress and felt much better the next day and headache is felt like when she had covid previously and feels like she is at the tail end of having the virus. She doesn't feel good and feeling so tired because of all of this. The patient has taken treatment of Excedrin migraine for the headaches also taken Tylenol and when she got desperate, she took a sumatriptan, a product used for migraines. The patient did not diagnose with COVID-19 since the vaccination. The outcome of event arm was very sore is recovering. The outcome of events Headache and doesn't feel good and tired is not recovered.  Follow-up attempts are completed. No further information is expected.
arm redness; did not received 2 dose; arm is swollen; arm soreness returned; Pretty Sick; Racing Heart Issues; delayed COVID arm reaction; arm tenderness; arm was hot; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Pretty Sick), HEART RATE INCREASED (Racing Heart Issues), TYPE IV HYPERSENSITIVITY REACTION (delayed COVID arm reaction), TENDERNESS (arm tenderness) and FEELING HOT (arm was hot) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information reported.     On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced FEELING HOT (arm was hot). On 08-Mar-2021, the patient experienced ILLNESS (Pretty Sick), HEART RATE INCREASED (Racing Heart Issues), TYPE IV HYPERSENSITIVITY REACTION (delayed COVID arm reaction), TENDERNESS (arm tenderness) and PAIN IN EXTREMITY (arm soreness returned). On 02-May-2021, the patient experienced PERIPHERAL SWELLING (arm is swollen). On an unknown date, the patient experienced ERYTHEMA (arm redness) and PRODUCT DOSE OMISSION ISSUE (did not received 2 dose). On 15-Mar-2021, ILLNESS (Pretty Sick), HEART RATE INCREASED (Racing Heart Issues), TYPE IV HYPERSENSITIVITY REACTION (delayed COVID arm reaction), TENDERNESS (arm tenderness) and PAIN IN EXTREMITY (arm soreness returned) had resolved. At the time of the report, FEELING HOT (arm was hot), ERYTHEMA (arm redness), PERIPHERAL SWELLING (arm is swollen) and PRODUCT DOSE OMISSION ISSUE (did not received 2 dose) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications reported. Patient reports treating events with Benadryl in March. The patient explains that she did not receive the second dose of the Moderna Covid-19 vaccine because the first dose made her "pretty sick" and she had some "racing heart issues".
my brother had a heart attack after they got the modernist shot; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MYOCARDIAL INFARCTION (my brother had a heart attack after they got the modernist shot) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDIAL INFARCTION (my brother had a heart attack after they got the modernist shot) (seriousness criterion medically significant). At the time of the report, MYOCARDIAL INFARCTION (my brother had a heart attack after they got the modernist shot) outcome was unknown.            No concomitant medications were provided by the reporter.  No treatment medications were provided by the reporter.  Company comment: This spontaneous case concerns a male patient of unknown age with no medical history information reported, who experienced the unexpected serious (medically significant) AESI of myocardial infarction. The event occurred approximately three weeks after a dose of mRNA-1273 bivalent BA.4/BA.5. No information about dose number or vaccination schedule was provided. As reported, patient had a heart attack after they got the modernist shot. No further information about the event was provided, including any diagnostic findings. The benefit-risk relationship of mRNA-1273 bivalent BA.4/BA.5 is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2022-689938, US-MODERNATX, INC.-MOD-2022-693527 (Linked Report).   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a male patient of unknown age with no medical history information reported, who experienced the unexpected serious (medically significant) AESI of myocardial infarction. The event occurred approximately three weeks after a dose of mRNA-1273 bivalent BA.4/BA.5. No information about dose number or vaccination schedule was provided. As reported, patient had a heart attack after they got the modernist shot. No further information about the event was provided, including any diagnostic findings. The benefit-risk relationship of mRNA-1273 bivalent BA.4/BA.5 is not affected by this report. US-MODERNATX, INC.-MOD-2022-689938:Daughter case US-MODERNATX, INC.-MOD-2022-693527:Sister case